Washington state health experts on Friday responded to federal advisers and regulators calling for a resumption of Johnson & Johnson COVID-19 vaccine after an 11-day break, responding to 15 women who were developing blood transfusions from nearly 8 million people.
The Centers for Disease Control and Prevention, as well as the Food and Drug Administration, announced that the break had been lifted immediately after the CDC’s advisory staff resumed staffing.
It was unclear when the one-dose son onson և oh john onson shots could be resumed in Washington state.
The State Department says it will not have new information until the Western United States Scientific Safety Review Working Group at 4pm on Friday evening. 30-6: 30. That group may suggest resuming shooting.
But health experts and officials rushed to help son onson և oh john onson end the break.
“This is a very strong vaccine, we need all the vaccines we need to stop this epidemic,” Deborah Fuller, a vaccine expert at the University of Washington, told a news conference Friday afternoon.
The discontinuation occurred in Washington just two days ago when the state opened the vaccine to anyone 16 16 բարձր older, և clinics who planned to run er onson և John onson, or canceled appointments or switched to the other two vaccines, Pfizer-BioNTech և Moderna both demand. two doses.
“Single-shot shots make up a significant portion of the state’s vaccine delivery,” Mikel Roberts, the assistant secretary of health, told a DOH briefing earlier this week. The state expects to receive about 4,300 doses in early May.
Dr. FFF Ducin, Seattle ինգ King County Public Health Officer, said Friday that the CDC Advisory Committee clarified that the benefits of resuming the vaccine with the onson ս ons և John onson vaccine outweigh the risks to individuals ամբողջ the entire U.S. population. ,
Citing modeling shared with an advisory committee over the next six months, Ducin said the country could expect 26-46 cases of rare vaccine-related blood tissue. During the same period, the vaccine is projected to prevent between 600 and 1,400 deaths from COVID-19, depending on absorption և transmission.
“The benefits obviously outweigh the risks, but people need to be able to understand the risk, to choose which vaccine they prefer, which is best for their particular situation,” Ducin said.
Ducin said the increase in COVID-19 cases in King County due to coronavirus infections increases the risk of waiting for the preferred vaccine.
“As the epidemic grows, you need to weigh your preferences with the risk of getting vaccinated, the risk of waiting,” Ducin said, adding that it is the best option for people who live in crowded places or work in high-risk jobs. It is to be vaccinated as soon as possible. ”
The CDC Advisory Committee said that women’s health care providers should be warned about the dangers of blood tissue. Of those who caused the rare blood clot, all were women, most of whom were under 50 years old. Fuller compared the warning to people with egg allergies to the flu vaccine, which has a lower risk of developing an allergic reaction.
Duchin said vaccine suppliers would provide onson և John Onson vaccine recipients with warning, practical information about symptoms associated with rare blood clotting syndrome, including shortness of breath, chest pain, swelling of the legs, persistent abdominal pain, and pain. as blurred vision or severe and persistent headaches.
“The headaches associated with this syndrome are different. “It usually happens later, on the sixth day. It’s trying to stay strong,” Ducin said, urging people to follow up on any post-vaccination symptoms. “If you have this rare syndrome, it is helpful to find out, diagnose and treat it.”
Dr. Seth Cohen, medical director of infection prevention at the University of Washington Medical Center, said he was not aware of any UW patients who had any symptoms.
In Washington state, according to the DOH, about 2.05 million people are fully vaccinated.